secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2026-10-09T21:19:26+00:00
Accession:  0001708599-26-000060
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Serina Therapeutics eliminates Series A Preferred stock designation after all shares convert to common
--------------------------------------------------------------------------------

- Certificate of Elimination filed with Delaware Secretary of State on October 5, 2026, removing all Series A Convertible Preferred terms from the charter.
- Series A Certificate of Designations originally filed April 10, 2025, and corrected May 22, 2025; no Series A Preferred shares remain outstanding.
- All issued Series A Preferred converted into common stock, and none will be issued; eliminated shares revert to authorized but unissued undesignated preferred stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859926000060/0001708599-26-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859926000060/ser-20261005.htm
  HTML page:      https://secwatch.observer/filing/0001708599-26-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer